1. Home
  2. BFRI vs KWE Comparison

BFRI vs KWE Comparison

Compare BFRI & KWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BFRI
  • KWE
  • Stock Information
  • Founded
  • BFRI 1997
  • KWE 2017
  • Country
  • BFRI United States
  • KWE Canada
  • Employees
  • BFRI N/A
  • KWE N/A
  • Industry
  • BFRI Biotechnology: Pharmaceutical Preparations
  • KWE
  • Sector
  • BFRI Health Care
  • KWE
  • Exchange
  • BFRI Nasdaq
  • KWE Nasdaq
  • Market Cap
  • BFRI 6.2M
  • KWE 2.3M
  • IPO Year
  • BFRI 2021
  • KWE N/A
  • Fundamental
  • Price
  • BFRI $1.11
  • KWE $0.14
  • Analyst Decision
  • BFRI Strong Buy
  • KWE
  • Analyst Count
  • BFRI 1
  • KWE 0
  • Target Price
  • BFRI $7.00
  • KWE N/A
  • AVG Volume (30 Days)
  • BFRI 344.5K
  • KWE 1.5M
  • Earning Date
  • BFRI 08-14-2024
  • KWE 08-16-2024
  • Dividend Yield
  • BFRI N/A
  • KWE N/A
  • EPS Growth
  • BFRI N/A
  • KWE N/A
  • EPS
  • BFRI N/A
  • KWE N/A
  • Revenue
  • BFRI $35,241,000.00
  • KWE $1,132,395.00
  • Revenue This Year
  • BFRI $19.11
  • KWE $817.82
  • Revenue Next Year
  • BFRI $20.16
  • KWE N/A
  • P/E Ratio
  • BFRI N/A
  • KWE N/A
  • Revenue Growth
  • BFRI 21.33
  • KWE 75.25
  • 52 Week Low
  • BFRI $0.61
  • KWE $0.13
  • 52 Week High
  • BFRI $9.52
  • KWE $1.92
  • Technical
  • Relative Strength Index (RSI)
  • BFRI 47.73
  • KWE 35.11
  • Support Level
  • BFRI $1.05
  • KWE $0.14
  • Resistance Level
  • BFRI $1.24
  • KWE $0.17
  • Average True Range (ATR)
  • BFRI 0.12
  • KWE 0.02
  • MACD
  • BFRI -0.01
  • KWE 0.01
  • Stochastic Oscillator
  • BFRI 20.37
  • KWE 14.55

About BFRI Biofrontera Inc.

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Its licensed product is Ameluz, which is a prescription drug approved for use in combination with the RhodoLED lamp series, for PDT (when used together, Ameluz PDT). including the complementary product BF-RhodoLED, and Xepi.

About KWE KWESST Micro Systems Inc.

KWESST Micro Systems Inc develops and commercializes next-generation tactical systems. The company offers breakthrough technology in lethal and non-lethal systems with broad application, including law enforcement and personal defence, modernized digitization of tactical forces for shared situational awareness and targeting, and counter-measures against threats such as drones, lasers and electronic detection.

Share on Social Networks: